Prognostic impact of lymphocytes in soft tissue sarcomas
- PMID: 21298041
- PMCID: PMC3029277
- DOI: 10.1371/journal.pone.0014611
Prognostic impact of lymphocytes in soft tissue sarcomas
Abstract
Purpose: The purpose of this study was to clarify the prognostic significance of lymphocyte infiltration in soft tissue sarcomas (STS). Prognostic markers in potentially curable STS should guide therapy after surgical resection. The immune status at the time of resection may be important, but the prognostic significance of tumor infiltrating lymphocytes is controversial as the immune system has conflicting roles during cancer development.
Experimental design: Tissue microarrays from 249 patients with STS were constructed from duplicate cores of viable and representative neoplastic tumor areas. Immunohistochemistry was used to evaluate the CD3+, CD4+, CD8+, CD20+ and CD45+ lymphocytes in tumors.
Results: In univariate analyses, increased numbers of CD4+ (P = 0.008) and CD20+ (P = 0.006) lymphocytes in tumor correlated significantly with an improved disease-specific survival (DSS) in patients with wide resection margins (n = 108). In patients with non-wide resection margins (n = 141) increased numbers of CD3+ (P = 0.028) lymphocytes in tumor correlated significantly with shorter DSS. In multivariate analyses, a high number of CD20+ lymphocytes (HR = 5.5, CI 95% = 1.6-18.6, P = 0.006) in the tumor was an independent positive prognostic factor for DSS in patients with wide resections margins.
Conclusions: High density of CD20+ lymphocytes in STS with wide resection margins is an independent positive prognostic indicator for these patients. Further research is needed to define if CD20+ cells can modify tumors in a way that reduces disease progression and metastatic potential.
Conflict of interest statement
Figures



Similar articles
-
Prognostic impact of peritumoral lymphocyte infiltration in soft tissue sarcomas.BMC Clin Pathol. 2012 Feb 29;12:5. doi: 10.1186/1472-6890-12-5. BMC Clin Pathol. 2012. PMID: 22375962 Free PMC article.
-
Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.Clin Cancer Res. 2008 Aug 15;14(16):5220-7. doi: 10.1158/1078-0432.CCR-08-0133. Clin Cancer Res. 2008. PMID: 18698040
-
Immune-cell infiltration in high-grade soft tissue sarcomas; prognostic implications of tumor-associated macrophages and B-cells.Acta Oncol. 2023 Jan;62(1):33-39. doi: 10.1080/0284186X.2023.2172688. Epub 2023 Feb 14. Acta Oncol. 2023. PMID: 36786033
-
Prognostic impact of Jab1, p16, p21, p62, Ki67 and Skp2 in soft tissue sarcomas.PLoS One. 2012;7(10):e47068. doi: 10.1371/journal.pone.0047068. Epub 2012 Oct 5. PLoS One. 2012. PMID: 23071715 Free PMC article.
-
Infiltration of CD8+ lymphocytes is an independent prognostic factor of biochemical failure-free survival in prostate cancer.Prostate. 2014 Oct;74(14):1452-61. doi: 10.1002/pros.22862. Epub 2014 Aug 11. Prostate. 2014. PMID: 25111810
Cited by
-
Interleukin-7 and immune reconstitution in cancer patients: a new paradigm for dramatically increasing overall survival.Target Oncol. 2012 Mar;7(1):55-68. doi: 10.1007/s11523-012-0210-4. Epub 2012 Mar 2. Target Oncol. 2012. PMID: 22383042 Free PMC article. Review.
-
LAG-3 expression on tumor-infiltrating T cells in soft tissue sarcoma correlates with poor survival.Cancer Biol Med. 2019 May;16(2):331-340. doi: 10.20892/j.issn.2095-3941.2018.0306. Cancer Biol Med. 2019. PMID: 31516753 Free PMC article.
-
Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment.Hum Pathol. 2015 Mar;46(3):357-65. doi: 10.1016/j.humpath.2014.11.001. Epub 2014 Nov 15. Hum Pathol. 2015. PMID: 25540867 Free PMC article.
-
Specific immune landscapes and immune checkpoint expressions in histotypes and molecular subtypes of sarcoma.Oncoimmunology. 2020 Jul 12;9(1):1792036. doi: 10.1080/2162402X.2020.1792036. Oncoimmunology. 2020. PMID: 32923153 Free PMC article.
-
Facts and Hopes in Immunotherapy of Soft-Tissue Sarcomas.Clin Cancer Res. 2020 Nov 15;26(22):5801-5808. doi: 10.1158/1078-0432.CCR-19-3335. Epub 2020 Jun 29. Clin Cancer Res. 2020. PMID: 32601077 Free PMC article. Review.
References
-
- Gustafson P. Soft tissue sarcoma. Epidemiology and prognosis in 508 patients. Acta Orthop Scand Suppl. 1994;259:1–31. - PubMed
-
- Engellau J, Anderson H, Rydholm A, Bauer HC, Hall KS, et al. Time dependence of prognostic factors for patients with soft tissue sarcoma: a Scandinavian Sarcoma Group Study of 338 malignant fibrous histiocytomas. Cancer. 2004;100:2233–2239. - PubMed
-
- Dickinson IC, Whitwell DJ, Battistuta D, Thompson B, Strobel N, et al. Surgical margin and its influence on survival in soft tissue sarcoma. ANZ J Surg. 2006;76:104–109. - PubMed
-
- Kiatisevi P, Asavamongkolkul A, Phimolsarnti R, Waikakul S, Benjarassamerote S. The outcomes and prognostic factors of patients with soft-tissue sarcoma. J Med Assoc Thai. 2006;89:334–342. - PubMed
-
- Koea JB, Leung D, Lewis JJ, Brennan MF. Histopathologic type: an independent prognostic factor in primary soft tissue sarcoma of the extremity? Ann Surg Oncol. 2003;10:432–440. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous